Comparison of the Efficacy and Safety of Fixed-Dose Amlodipine/Losartan and Losartan in Hypertensive Patients Inadequately Controlled with Losartan: A Randomized, Double-Blind, Multicenter Study

By Hong Bum-Kee  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 3, 2012-06 ,pp. : 189-195

Adis International

Access to resources Recommend Favorite

Encapsulation of Commercially Available Losartan for Blinding Purposes Does Not Affect its Bioavailability

By Nyman L.  

Clinical Drug Investigation, Vol. 15, Iss. 4, 1998-04 ,pp. : 361-365

Adis International

Access to resources Recommend Favorite

Effects of a therapy with losartan and quinaprilat on the progression of chronic renal failure in rats after a single dose of uranyl nitrate or 5/6 nephrectomy

By Appenroth Dorothea   Beutinger Ralf   Lupp Amelie   Fleck Christian  

Experimental and Toxicologic Pathology, Vol. 54, Iss. 5-6, 2003-05 ,pp. : 359-366

Urban & Fischer

Access to resources Recommend Favorite

Angiotensin II-Receptor Antagonist Losartan Does not Prevent Nitroglycerin Tolerance in Patients with Coronary Artery Disease

By Longobardi Giancarlo   Ferrara Nicola   Leosco Dario   Abete Pasquale   Furgi Giuseppe   Cacciatore Francesco   Corbi Graziamaria   Pescatore Raffaella   Rengo Franco  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 5, 2004-09 ,pp. : 363-370

Springer Publishing Company

Access to resources Recommend Favorite

Does the Angiotensin II Receptor Antagonist Losartan Improve Cognitive Function?

By Tedesco M.A.   Ratti G.   Di Salvo G.   Natale F.  

Drugs & Aging, Vol. 19, Iss. 10, 2002-01 ,pp. : 723-732

Adis International

Access to resources Recommend Favorite